Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies

Katharina Stegmayer, Sebastian Walther, Peter van Harten

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)135-147
Number of pages13
JournalCns Drugs
Volume32
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • DEEP BRAIN-STIMULATION
  • OF-THE-LITERATURE
  • SCHIZOPHRENIA SPECTRUM DISORDERS
  • ABNORMAL INVOLUNTARY MOVEMENTS
  • NEUROLEPTIC-INDUCED DYSKINESIA
  • RANDOMIZED CONTROLLED-TRIAL
  • FOLLOW-UP
  • DOUBLE-BLIND
  • BOTULINUM TOXIN
  • MOTOR ABNORMALITIES

Cite this

@article{22a2caf20b2a4e37a595f042fde17d3b,
title = "Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies",
keywords = "DEEP BRAIN-STIMULATION, OF-THE-LITERATURE, SCHIZOPHRENIA SPECTRUM DISORDERS, ABNORMAL INVOLUNTARY MOVEMENTS, NEUROLEPTIC-INDUCED DYSKINESIA, RANDOMIZED CONTROLLED-TRIAL, FOLLOW-UP, DOUBLE-BLIND, BOTULINUM TOXIN, MOTOR ABNORMALITIES",
author = "Katharina Stegmayer and Sebastian Walther and {van Harten}, Peter",
year = "2018",
month = "2",
day = "1",
doi = "10.1007/s40263-018-0494-8",
language = "English",
volume = "32",
pages = "135--147",
journal = "Cns Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",
number = "2",

}

Tardive Dyskinesia Associated with Atypical Antipsychotics : Prevalence, Mechanisms and Management Strategies. / Stegmayer, Katharina; Walther, Sebastian; van Harten, Peter.

In: Cns Drugs, Vol. 32, No. 2, 01.02.2018, p. 135-147.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Tardive Dyskinesia Associated with Atypical Antipsychotics

T2 - Prevalence, Mechanisms and Management Strategies

AU - Stegmayer, Katharina

AU - Walther, Sebastian

AU - van Harten, Peter

PY - 2018/2/1

Y1 - 2018/2/1

KW - DEEP BRAIN-STIMULATION

KW - OF-THE-LITERATURE

KW - SCHIZOPHRENIA SPECTRUM DISORDERS

KW - ABNORMAL INVOLUNTARY MOVEMENTS

KW - NEUROLEPTIC-INDUCED DYSKINESIA

KW - RANDOMIZED CONTROLLED-TRIAL

KW - FOLLOW-UP

KW - DOUBLE-BLIND

KW - BOTULINUM TOXIN

KW - MOTOR ABNORMALITIES

U2 - 10.1007/s40263-018-0494-8

DO - 10.1007/s40263-018-0494-8

M3 - Review article

VL - 32

SP - 135

EP - 147

JO - Cns Drugs

JF - Cns Drugs

SN - 1172-7047

IS - 2

ER -